Embla Medical hf · OMXCOP:EMBLA

Embla Medical hf financial statements

Embla Medical hf's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue963.6M854.9M799.1M718.6M718.7M629.5M686.3M612.9M568.6M520.7M
Cost of revenue403.0M320.2M300.1M278.9M263.3M238.3M247.6M226.1M213.8M192.3M
Gross profit560.6M534.7M485.6M439.7M455.4M391.2M438.6M386.8M354.8M328.4M
Research and development41.0M40.8M38.1M34.0M31.7M31.0M31.3M31.4M28.9M23.2M
Selling, general and administrative73.8M70.0M66.9M72.5M74.1M77.7M76.0M70.3M63.7M58.1M
Operating income129.4M112.8M89.4M67.1M95.6M53.3M99.2M90.5M80.5M72.2M
Depreciation and amortization62.9M56.0M49.9M49.4M51.5M64.7M43.6M28.4M22.6M21.7M
EBITDA192.3M168.7M139.3M116.5M147.2M118.0M142.8M118.9M103.0M93.9M
Interest expense21.9M23.2M18.0M11.2M9.80M9.61M8.33M3.76M3.20M2.73M
Income before tax112.0M90.6M76.0M56.2M86.6M12.7M90.3M96.9M68.7M68.4M
Income tax25.2M21.6M17.2M13.0M21.0M4.80M21.4M17.1M11.1M17.4M
Net income86.5M68.3M58.4M42.5M64.0M6.21M66.0M79.8M57.6M51.0M
Earnings per share, basic0.200.160.140.100.150.010.160.190.130.12

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents102.3M86.2M72.7M76.6M85.2M102.4M58.6M55.7M37.3M35.1M
Receivables153.2M121.9M151.0M131.2M120.7M124.8M131.0M118.4M108.4M96.2M
Inventory165.3M143.1M136.2M132.1M104.0M93.2M112.0M95.9M82.3M75.3M
Current assets457.0M397.0M376.0M348.8M318.2M326.5M307.4M274.0M232.2M210.7M
Goodwill833.7M776.3M690.9M680.4M644.2M612.2M521.0M500.8M414.7M394.1M
Total assets1.74B1.54B1.39B1.33B1.25B1.21B1.09B913.6M793.0M746.4M
Accounts payable32.8M27.3M30.7M28.7M26.7M20.0M26.7M28.1M23.4M17.8M
Current liabilities308.9M209.3M196.2M237.0M186.5M147.3M141.1M117.6M126.8M114.0M
Long-term debt292.2M328.8M311.8M277.7M262.2M340.0M
Total debt541.6M499.8M467.7M480.9M448.2M483.4M360.2M235.5M158.7M154.5M
Total liabilities848.7M758.3M680.7M689.9M620.3M637.1M521.7M376.0M292.6M279.2M
Shareholders' equity888.6M777.2M701.9M635.7M621.6M572.5M564.4M534.5M499.9M466.4M
Shares outstanding427.0M426.7M420.3M417.8M422.8M422.7M424.6M426.5M432.4M440.7M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations141.8M116.1M94.3M60.8M100.5M92.2M95.3M69.4M73.9M66.3M
Capital spending-22.9M-39.2M-42.3M-25.9M-26.7M-24.0M-31.9M-30.9M-19.2M-24.6M
Free cash flow118.9M76.8M52.0M34.8M73.8M68.2M63.4M38.6M54.7M41.7M
Cash from investing-57.4M-57.1M-66.3M-59.4M-106.4M-62.4M-92.1M-19.4M-86.9M
Cash from financing-72.3M-41.0M3.79M-51.1M51.9M-29.3M44.4M-56.4M31.9M
Dividends paid-9.28M-9.06M-9.18M-7.34M-7.81M
Share buybacks-10.1M00-9.94M0-3.94M-20.6M-19.3M-36.1M-27.8M
Change in cash4.93M17.1M-3.98M-8.57M-17.2M43.8M2.90M18.4M2.18M9.38M